Gilead Sciences Inc Stock
Price
Target price
€66.72
€66.72
-0.950%
-0.64
-0.950%
€85.27
19.07.24 / Tradegate
WKN: 885823 / Symbol: GILD / Name: Gilead Sciences / Stock / Biotechnology & Medical Research / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Gilead Sciences Inc Stock
The price for the Gilead Sciences Inc stock decreased slightly today. Compared to yesterday there is a change of -€0.640 (-0.950%).
With 11 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
As a result the target price of 85 € shows a positive potential of 27.4% compared to the current price of 66.72 € for Gilead Sciences Inc.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Gilead Sciences Inc stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Gilead Sciences Inc in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
B****
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Gilead Sciences Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Gilead Sciences Inc | -0.950% | 4.006% | 0.969% | -7.947% | -8.753% | 15.134% | 14.876% |
| Incyte Corp. | 0.870% | 3.735% | 2.367% | 5.031% | 6.697% | -9.723% | -15.411% |
| Regeneron Pharmaceuticals Inc. | -0.290% | -3.053% | -0.711% | 48.100% | 22.658% | 97.816% | 260.494% |
| Exact Sciences | -0.570% | 1.188% | 2.550% | -49.614% | -37.210% | -56.910% | -58.223% |
Comments
Gilead Sciences, Inc. (NASDAQ: GILD) was upgraded by analysts at Raymond James from a "market perform" rating to an "outperform" rating. They now have a $93.00 price target on the stock.
Show more
Ratings data for GILD provided by MarketBeat
Gilead Sciences, Inc. (NASDAQ: GILD) had its price target lowered by analysts at Maxim Group from $90.00 to $85.00. They now have a "buy" rating on the stock.
Show more
Ratings data for GILD provided by MarketBeat
Gilead Sciences, Inc. (NASDAQ: GILD) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Show more
Ratings data for GILD provided by MarketBeat
